市值低于现金的企业，是机会吗_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":170308958,"tweetId":"170308958","gmtCreate":1626402275174,"gmtModify":1626402275174,"author":{"id":3452938437060827,"authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6126,"starInvestorFlag":false},"themes":[{"themeId":"3dedd76b82b147d9878afe8793c4b4c8","categoryId":"7ba93224048e4975aa9a5a60d7f2353b","name":"下一个美股打新，会是大肉签吗？","type":3,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/discussion&rndata={\"themeId\":3dedd76b82b147d9878afe8793c4b4c8}&rnconfig={\"headerBarHidden\": true}","description":"药明康德、红杉资本等投资的天演药业和SaaS第一中概股容联云将在本月上市，2020年上市的中概股表现优异，这两家你看好吗？","image":"https://static.tigerbbs.com/109478ac79e7b1010aba611ffde0b0b2"}],"images":[],"coverImages":[],"title":"市值低于现金的企业，是机会吗","extraTitle":"","html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a>&nbsp;市值37亿美元，账上有近50亿欧元。股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。<a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a>&nbsp;</body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a>&nbsp;市值37亿美元，账上有近50亿欧元。股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。<a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a>&nbsp;</body></html>","text":"$Galapagos NV(GLPG)$ 市值37亿美元，账上有近50亿欧元。 股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据： 治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。 $翰森制药(03692)$ $天境生物(IMAB)$ $天演药业(ADAG)$ $康乃德生物医药(CNTB)$","highlighted":1,"essential":1,"paper":2,"likeSize":14,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/170308958","repostId":0,"isVote":1,"tweetType":1,"viewCount":5775,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ADAG","IMAB","03692","CNTB","GLPG"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":352,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":5279161,"gmtCreate":1626834803290,"gmtModify":1626834803290,"authorId":3573102416837786,"author":{"id":3573102416837786,"authorId":3573102416837786,"name":"小滴","avatar":"https://static.tigerbbs.com/db4a32287ea6634d9257724dc05b64f0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170308958,"type":1,"supId":0,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

市值低于现金的企业，是机会吗

评论（1）

热议股票